Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Infect Dis Clin North Am. 2010 Dec;24(4):871–884. doi: 10.1016/j.idc.2010.07.006

Table 3.

Diagnostic tests for cholangiocarcinoma

Diagnostic test Sensitivity

Tumor markers
 CA19.9 80–90%
 CEA 30%

Radiology
 Computational Tomography (CT) 50–60%
 Magnetic Resonance Imaging (MRI) 50–90%
 Intraductal ultrasound 89–95%

Endoscopy
 Cholangiography and sampling 45–75%

Nuclear medicine
 PET 85% (18% in infiltrative CCA)

Cytology analysis
 Routine cytology 16–68%
 Digital Imaging Analysis (DIA) 44%
 Fluorescence In Situ Hybridization (FISH) 43%